Venture Life Group Plc (VLG):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Venture Life Group Plc (VLG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8126
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Venture Life Group Plc (Venture Life) is a consumer goods company that offers ageing population products. The groups product and pipeline comprise food supplements for lowering cholesterol and maintaining brain function, medical devices for improving minor aches and pains, dry eyes and itchy skin and dermo-cosmetics for addressing the signs of ageing. It also provides cardiovascular products, dermatology products, neurology products, oral healthcare products, proctology products, and women’s healthcare products, among others. Venture Life offers development and manufacturing services to companies in the medical device and cosmetic sectors. The group also conducts research in the therapeutic areas of dermatology, cardiovascular, neurology, rheumatology, and ophthalmology. It markets its products in the UK and abroad. Venture Life is headquartered in Bracknell, the UK.

Venture Life Group Plc (VLG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Venture Life Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Venture Life Group Plc, Medical Devices Deals, 2012 to YTD 2018 9
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
OptiBiotix Health Enters into an Agreement with Venture Life 11
Venture Life Enters into Distribution Agreement with DEEF Pharma 12
Venture Life Enters into Distribution Agreement with Hikma Pharma 13
Venture Life Enters into Distribution Agreement with Pharma Deen 14
Equity Offering 15
Venture Life Group Raises USD9 Million in IPO 15
Acquisition 16
Venture Life Group Acquires Biokosmes 16
Venture Life Group Plc – Key Competitors 17
Venture Life Group Plc – Key Employees 18
Venture Life Group Plc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
Sep 20, 2018: Venture Life Group appoints Carl Dempsey as a Non-Executive Director 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Venture Life Group Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Venture Life Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Venture Life Group Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Venture Life Group Plc, Medical Devices Deals, 2012 to YTD 2018 9
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
OptiBiotix Health Enters into an Agreement with Venture Life 11
Venture Life Enters into Distribution Agreement with DEEF Pharma 12
Venture Life Enters into Distribution Agreement with Hikma Pharma 13
Venture Life Enters into Distribution Agreement with Pharma Deen 14
Venture Life Group Raises USD9 Million in IPO 15
Venture Life Group Acquires Biokosmes 16
Venture Life Group Plc, Key Competitors 17
Venture Life Group Plc, Key Employees 18
Venture Life Group Plc, Subsidiaries 19

List of Figures
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Venture Life Group Plc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Venture Life Group Plc (VLG):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Israel Chemicals Ltd (ICL):企業の財務・戦略的SWOT分析
    Israel Chemicals Ltd (ICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Cellnovo Ltd-医療機器分野:企業M&A・提携分析
    Summary Cellnovo Ltd (Cellnovo), formerly Starbridge Systems Ltd is a provider of conventional diabetes care technology solutions. The company offers mobile diabetes management system, including an insulin patch pump, activity monitor, cellular-enabled wireless touchscreen handset with integrated bl …
  • Guardian Media Group plc:企業の戦略・SWOT・財務情報
    Guardian Media Group plc - Strategy, SWOT and Corporate Finance Report Summary Guardian Media Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • State Street Corporation:企業のM&A・事業提携・投資動向
    State Street Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's State Street Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Genomic Vision SA (GV):企業の財務・戦略的SWOT分析
    Summary Genomic Vision (Genomic) is a molecular diagnostics and technology company that develops and commercializes diagnostic tests for genetic diseases and cancers. The company’s portfolio comprises tests for breast cancer and colon cancer, diagnostic solution for facio-scapulo-humeral muscular dy …
  • Victorian WorkCover Authority:企業の戦略的SWOT分析
    Victorian WorkCover Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Edgemont Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Edgemont Pharmaceuticals LLC (Edgemont) is a pharmaceutical company that develops, acquires, and markets products for the treatment of psychiatric disorders. The company focuses on the development of novel drug formulations and therapies in the field of neuroscience. Its portfolio of product …
  • Hemanext:製薬・医療:M&Aディール及び事業提携情報
    Summary Hemanext, formerly New Health Sciences Inc, is a medical technology company that develops blood storage systems. The company offers an anaerobic storage system that minimizes oxidative damage to red blood cells in storage and delivers physiologic, therapeutic, and fresher red blood cell than …
  • Severoceske doly as:企業の戦略・SWOT・財務情報
    Severoceske doly as - Strategy, SWOT and Corporate Finance Report Summary Severoceske doly as - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Milestone Scientific Inc (MLSS):製品パイプライン分析
    Summary Milestone Scientific Inc (Milestone Scientific) is a medical device company that designs, manufactures and distributes computer controlled drug delivery instruments. The company provides medical products and dental products. Its medical products include epidurals, intra-articular injections, …
  • Vilniaus Degtine AB:企業の戦略・SWOT・財務分析
    Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report Summary Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ctrip.com International, Ltd.:企業の戦略・SWOT・財務情報
    Ctrip.com International, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ctrip.com International, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Vestas Wind Systems A/S:企業の戦略・SWOT・財務分析
    Vestas Wind Systems A/S - Strategy, SWOT and Corporate Finance Report Summary Vestas Wind Systems A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Studsvik AB (SVIK):企業の財務・戦略的SWOT分析
    Studsvik AB (SVIK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Galp Energia SGPS SA (GALP):石油・ガス:M&Aディール及び事業提携情報
    Summary Galp Energia SGPS SA (Galp) is an integrated energy company. It explores for, develops and produces crude oil and natural gas, refines crude oil, and markets refined petroleum products. The company also conducts power generation, produces biodiesel and trades gas. It imports, transports and …
  • Biolife Solutions Inc (BLFS):企業の財務・戦略的SWOT分析
    Summary BioLife Solutions Inc (BioLife Solutions) is a developer, manufacturer and supplier of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media for cells and tissues. The company offers serum-free and protein-free solutions, which are formulated to red …
  • Basilea Pharmaceutica Ltd (BSLN):企業の財務・戦略的SWOT分析
    Summary Basilea Pharmaceutica Ltd (Basilea) is a biopharmaceutical company that develops and markets antibiotics, antifungals and oncology drugs. The company’s products address increasing resistance and non-response to present treatment options for various therapeutic areas such as cancer, bacterial …
  • Mapletree Commercial Trust Management Ltd:企業の戦略・SWOT・財務情報
    Mapletree Commercial Trust Management Ltd - Strategy, SWOT and Corporate Finance Report Summary Mapletree Commercial Trust Management Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • BioTime Inc (BTX)-医療機器分野:企業M&A・提携分析
    Summary BioTime Inc (BioTime) is a biotechnology company which focuses on regenerative medicine and plasma volume expanders. The company’s Hextend is a blood plasma volume expander used for the treatment of hypovolemia in surgery, emergency trauma treatment, and other applications. It is also develo …
  • Pental Limited (PTL):企業の財務・戦略的SWOT分析
    Pental Limited (PTL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆